FFA
ONC

Farther Finance Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Farther Finance Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.2K Buy
267
+45
+20% +$13.3K ﹤0.01% 2922
2026
Q1 		$68.5K Buy
222
+4
+2% +$1.29K ﹤0.01% 2773
2025
Q4 		$66.2K Buy
218
+39
+22% +$12.8K ﹤0.01% 2625
2025
Q3 		$61K Buy
179
+19
+12% +$5.77K ﹤0.01% 2332
2025
Q2 		$38.7K Buy
160
+64
+67% +$15.7K ﹤0.01% 2260
2025
Q1 		$26K Buy
96
+12
+14% +$2.81K ﹤0.01% 2253
2024
Q4 		$15.5K Buy
84
+69
+460% +$14.1K ﹤0.01% 2193
2024
Q3 		$3.37K Buy
15
+4
+36% +$720 ﹤0.01% 2803
2024
Q2 		$1.59K Sell
11
-32
-74% -$4.93K ﹤0.01% 2882
2024
Q1 		$6.85K Sell
43
-2
-4% -$322 ﹤0.01% 1927
2023
Q4 		$8.12K Buy
45
+21
+88% +$3.8K ﹤0.01% 1711
2023
Q3 		$4.32K Buy
24
+5
+26% +$989 ﹤0.01% 1562
2023
Q2 		$3.39K Hold
19
– – ﹤0.01% 1567
2023
Q1 		$4.09K Buy
+19
New +$4.56K ﹤0.01% 1397

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Farther Finance Advisors's ONC Position: Q2 2026 in Review

Farther Finance Advisors increased its BeOne Medicines Ltd (ONC) stake by 20% in Q2 2026, buying an estimated $13.3K and bringing the position to 267 shares worth $76.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2922.

Farther Finance Advisors first reported a position in ONC in Q1 2023 and has held it in 14 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Farther Finance Advisors held 267 shares of BeOne Medicines Ltd worth $76.2K as of Q2 2026.
  • Farther Finance Advisors bought 45 BeOne Medicines Ltd shares in Q2 2026, an estimated $13.3K.
  • BeOne Medicines Ltd made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2922 holding.
  • Farther Finance Advisors first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 14 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.